全文获取类型
收费全文 | 284篇 |
免费 | 10篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 1篇 |
妇产科学 | 10篇 |
基础医学 | 17篇 |
口腔科学 | 5篇 |
临床医学 | 75篇 |
内科学 | 74篇 |
皮肤病学 | 8篇 |
神经病学 | 6篇 |
特种医学 | 3篇 |
外科学 | 27篇 |
预防医学 | 17篇 |
药学 | 47篇 |
肿瘤学 | 2篇 |
出版年
2021年 | 2篇 |
2020年 | 1篇 |
2017年 | 3篇 |
2016年 | 4篇 |
2015年 | 6篇 |
2014年 | 10篇 |
2013年 | 12篇 |
2012年 | 4篇 |
2011年 | 3篇 |
2010年 | 11篇 |
2009年 | 11篇 |
2008年 | 2篇 |
2007年 | 5篇 |
2006年 | 8篇 |
2005年 | 1篇 |
2004年 | 2篇 |
2003年 | 5篇 |
2002年 | 1篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 4篇 |
1998年 | 11篇 |
1997年 | 16篇 |
1996年 | 18篇 |
1995年 | 12篇 |
1994年 | 14篇 |
1993年 | 8篇 |
1992年 | 5篇 |
1991年 | 8篇 |
1990年 | 8篇 |
1989年 | 9篇 |
1988年 | 10篇 |
1987年 | 4篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 5篇 |
1983年 | 7篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1970年 | 1篇 |
1959年 | 4篇 |
1958年 | 4篇 |
1957年 | 8篇 |
1956年 | 3篇 |
1955年 | 6篇 |
1954年 | 4篇 |
1948年 | 2篇 |
排序方式: 共有294条查询结果,搜索用时 15 毫秒
51.
GIAN‐BATTISTA CHIERCHIA M.D. ANDREA SARKOZY M.D. CARLO DE ASMUNDIS M.D. STEPHAN‐ANDREAS MÜLLER‐BURRI M.D. YOSHINAO YAZAKI M.D. LUCIO CAPULZINI M.D. PEDRO BRUGADA M.D. Ph.D. 《Pacing and clinical electrophysiology : PACE》2011,34(11):e98-e101
Ablation of parahissian accessory pathways (APs) is a challenging procedure because of the high risk to provoke “iatrogenic” atrioventricular (AV) nodal block. The feasibility and safety of cryoablation (CA) have been already demonstrated both in patients with AV nodal reentry tachycardia and in those with anteroseptal APs. However, dissociation between anterograde and retrograde conduction after CA has not yet been described. We report two cases of CA of parahissian AP associated with transient dissociation between anterograde and retrograde conduction. (PACE 2011; 34:e98–e101) 相似文献
52.
Luigi Battaglia Michele Trotta Marina Gallarate M. Eugenia Carlotti GIAN Paolo Zara Alessandro Bargoni 《Journal of microencapsulation》2013,30(7):672-684
Insulin-loaded solid lipid nanoparticles (SLN), obtained by the solvent-in-water emulsion–diffusion technique, were produced using isovaleric acid (IVA) as organic phase, glyceryl mono-stearate (GMS) as lipid, soy lecithin and sodium taurodeoxycholate (TDC) as emulsifiers. IVA, a partially water-miscible solvent with low toxicity, was used to dissolve both insulin and lipids. SLN of spherical shape were obtained by simple water dilution of the O/W emulsion. Analysis of SLN content after processing showed interesting encapsulation efficiency with respect to therapeutic doses; moreover, insulin did not undergo any chemical modification within the nanoparticles and most of it remained stable after incubation of the SLN with trypsin solution. The biological activity of insulin, i.e. the ability to decrease glycemia in rats, was not negatively influenced by the SLN production process, as after subcutaneous administration of insulin extracted from SLN to animals, the blood glucose levels were quite similar to those obtained after administration of a conventional insulin suspension. Consequently, SLN seem to have interesting possibilities as delivery systems for oral administration of insulin. 相似文献
53.
54.
LAURA VIZZOTTO MAURIZIO VERTEMATI CARLO TOMMASINI DEGNA PAOLO ASENI 《Journal of anatomy》2000,198(5):603-610
Ischaemia and reperfusion phases represent critical events during liver transplantation. The purpose of this study was to describe morphological alterations of both vascular and parenchymal compartments after ischaemia and reperfusion and to evaluate the possible relationship between morphometric parameters and biochemical/clinical data. Three needle biopsies were drawn from 20 patients who underwent orthotopic liver transplantation. The first biopsy was taken before flushing with preservation solution, and the second and the third to evaluate respectively the effects of cold ischaemia and of warm ischaemia/reperfusion. Biopsies were examined by an image analyser and morphometric parameters related to the liver parenchyma were evaluated. At the second biopsy we observed a decrease of the endothelium volume fraction while the same parameter referred to the sinusoidal lumen achieved a peak value. The hepatocytes showed a lower surface parenchymal/vascular sides ratio. This parameter was reversed at the end of the reperfusion phase; furthermore the third biopsy revealed endothelial swelling and a decreased volume fraction of the sinusoidal lumen. The results quantify the damage to the sinusoidal bed which, as already known, is one of the main targets of cold ischaemia; warm ischaemia and reperfusion accentuate endothelial damage. The end of transplantation is characterised by damage chiefly to parenchymal cells. Hepatocytes show a rearrangement of their surface sides, probably related to the alterations of the sinusoidal bed. In addition, the fluctuations of morphometric parameters during ischaemia/reperfusion correlate positively with biochemical data and clinical course of the patients. 相似文献
55.
GIUSEPPE CICONTE M.D. JUAN SIEIRA‐MORET M.D. EBRU HACIOGLU M.D. GIACOMO MUGNAI M.D. GIACOMO DI GIOVANNI M.D. VEDRAN VELAGIC M.D. YUKIO SAITOH M.D. GIULIO CONTE M.D. Ph.D. GHAZALA IRFAN M.D. GIANNIS BALTOGIANNIS M.D. Ph.D. BURAK HUNUK M.D. ERWIN STROKER M.D. PEDRO BRUGADA M.D. Ph.D. CARLO DE ASMUNDIS M.D. Ph.D. F.H.R.S. GIAN‐BATTISTA CHIERCHIA M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2016,27(7):796-803
56.
57.
58.
FEDERICO NARCISI DANIELE CASTELLANI GIUSEPPE DI MARCO ANTONIO FILENI GIUSEPPE PARADISO GALATIOTO ADELE MANCINOTTI CARLO VICENTINI 《International journal of urology》2006,13(3):289-290
Endoscopic management of urolithiasis is one of the commonest urological procedures today. It is usually safe and effective but one of the possible complications is ureteral obstruction. Stone fragmentation after ballistic lithotripsy and ureteral wall perforation could explain the mechanism responsible for this occurrence. We report a case of stone granuloma, occurring after a ballistic ureterolithotripsy. 相似文献
59.
60.
DANIELE CORNACCHIA MAURO FABBRI ALEARDO MARESTA PASQUALE NIGRO FRANCESCO SORRENTINO REA PUGLISI RENATO RICCI CARLO PERALDO MASSIMO FAZZARI † GIANFRANCO PISTIS † PIERO SESTU ‡ DIONIGI MEREU ‡ FRANCESCO De SETA§ 《Pacing and clinical electrophysiology : PACE》1993,16(12):2279-2284
The aim of this study was to evaluate chronic ventricular pacing threshold increase after oral propafenone therapy. Eighty-three patients affected by advanced atrioventricular hJock and sick sinus syndrome were studied at least 3 months after pacemaker implantation, before and after oral propafenone therapy (450–900 mg/day based on body weight). The patients were subdivided into three groups according to the type of unipolar electrode that was implanted: group I (41 patients)Medtronic CapSure 4003, group II(30 patients)Medtronic Target Tip 4011, and group III (12 patients)Osypka Vy screw-in lead. In all cases a Medtronic unipolar pacemaker was implanted: 30 Minix, 23 Activitrax, 14 Elite, 12 Legend, and 4 Pasys. Propafenone biood level was measured in 75 patients 3–5 hours after propafenone administration. The pacing autothreshoid was measured at 0.8 V, 1.6 V, and 2.5 V by reducing puise width. At the three different outputs before and after propafenone, threshold increments were significantly lower in group I in comparison with group II and group III (propafenone ranging from < 0.001 to < 0.05). No significant difference was found in pacing impedance or in propafenone plasma concentration in the three groups. Strength-duration curves were drawn for each group at baseline and after propafenone administration. Before propafenone, in group I, the knee was markedly shifted to the left and downward as compared to the classic curve, so that the steep part was predominant; in group II and group III this shift was progressively less evident. After propafenone we found the curve shifted to the right with the flat part progressively more evident in group II and group III as compared to group I. We conclude that steroid eiuting leads cause less threshold increase than conventionol and screw-in ones after oral propafenone, thus leading to safer chronic pacing. Chronic pacing at 2.5-V amplitude and 0.6-msec width was feasible in 97% of group I patients and in 80% of group II patients, but not in group III due to an insufficient safety margin. propafenone, pacing threshold 相似文献